As retailers struggle to keep up with changing shopping trends, mall operators across the US are looking to fill spaces left empty by the likes of Sears and RadioShack. There is one promising new group of tenants: walk-in medical clinics.
As retailers struggle to keep up with changing shopping trends, mall operators across the US are looking to fill spaces left empty by the likes of Sears and RadioShack. There is one promising new group of tenants: walk-in medical clinics, staffed by doctors who can treat common ailments such as pink eye and minor injuries like sprains and burns.
The clinics—regional chains such as City Practice Group of New York and national ones like Concentra, the largest urgent-care organization in the US—are a growing segment of the medical retail industry, says Scott Mason, executive managing director of Cushman & Wakefield’s healthcare group. There were 9400 walk-in clinics in the US in 2013, according to the Urgent Care Association of America, a 20% increase since 2009. A little more than a third are located in strip malls and shopping centers.
Read more: http://buswk.co/17q1z2c
Source: Bloomberg Businessweek
Health Equity Adjustments in Medicare HVBP Program Will Benefit Safety Net Hospitals, Study Says
March 29th 2024Medicare’s upcoming health equity adjustment in the Hospital Value-Based Purchasing (HVBP) program will reduce disproportionate penalization among safety net hospitals and those serving high proportions of Black patients, according to a recent study.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
FDA Approves Ravulizumab-cwvz for Rare Autoimmune Disease
March 28th 2024Ravulizumab-cwvz (Ultomiris) received a label expansion by the FDA for the treatment of adult neuromyelitis optica spectrum disorder in patients with anti–aquaporin-4 antibodies after trials results showed it could prevent relapses.
Read More